MindMed grants 88,950 stock options to new hires

Mind Medicine (MindMed) Inc., a biopharmaceutical company focused on brain health disorders, has announced new stock options for four recently hired employees. The grants total 88,950 common shares and will take effect on March 24, 2025. The options come at an exercise price based on MindMed’s stock value from March 21, 2025. These options are set to vest over four years. Employees will receive 25% of the options after their first year and the rest in equal monthly amounts over the following three years, contingent on their continued employment. These inducement grants were approved by MindMed’s Compensation Committee on March 19, 2025. The move is part of the company's effort to attract talent as it develops new treatments for brain health issues. MindMed is listed on the NASDAQ under the ticker MNMD.